Search Within

Genitourinary Oncology Service

Formats
  1. Journal Article (2791)
  2. Meeting Abstract (2524)
  3. Review (119)
  4. Book Section (83)
  5. Editorial (57)
  6. Correspondence (34)
  7. Conference Paper (29)
  8. Guidelines (25)
  9. Research Letter (18)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Solid Tumor Oncology Division (5688)
  2. Department of Medicine (5678)
  3. GSK Faculty (1658)
  4. Human Oncology and Pathogenesis Program (1157)
  5. Department of Pathology and Laboratory Medicine (1129)
  6. Surgery (1020)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. David Solit (785)
  4. Dean Bajorin (663)
  5. Michael Morris (587)
  6. Jonathan Rosenberg (525)

More People

Years
  1. 2025 (197)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1713)
  2. Annals of Oncology (304)
  3. Clinical Cancer Research (283)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (121)

More Publications

Publishers
  1. American Society of Clinical Oncology (1780)
  2. American Association for Cancer Research (689)
  3. Oxford University Press (413)
  4. Elsevier Science, Inc. (394)
  5. Elsevier Inc. (380)
  6. Nature Publishing Group (302)

More Publishers

Results (5688)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immune-related adverse event prediction and influential factor identification
    Meeting Abstract

    Zhang, Y.; Lev-Ari, S.; Shah, N. J.; Gupta, S.; Zaemes, J. P.; Alaoui, A.; McGarvey, P.; Atkins, M. B.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Cancer care service use intensity in Medicare Advantage versus traditional Medicare
    Meeting Abstract

    Mitchell, A. P.; Kalidindi, Y.; Feldman, R.; Carlin, C.; Song, G.; Jung, J.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A multi-institution analysis of outcomes with first-line systemic therapy for 99 patients with metastatic chromophobe renal cell carcinoma
    Meeting Abstract

    Doshi, S. D.; Dizman, N.; Knezevic, A.; Touma, A.; Alaghehbandan, R.; Ged, Y.; Ornstein, M. C.; Hahn, A. W.; Msaouel, P.; Voss, M. H.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Real-world evidence of overall survival (OS) and treatment patterns of patients (pts) with testicular germ cell tumors (GCT) receiving palliative chemotherapy in the United States
    Meeting Abstract

    Feldman, D. R.; Habucky, K.; Gagnon-Sanschagrin, P.; Maitland, J.; Boileau, P.; Yokoji, K.; Guérin, A.; Joseph, G.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Personalized circulating tumor DNA for minimal residual disease and dynamic assessment in patients undergoing neoadjuvant chemotherapy for breast cancer: Preliminary analysis from MSK-LINC
    Meeting Abstract

    Kim, H. K.; An, J. A. R.; Smith, C. G.; Kim, J.; Cabel, L.; Moiso, E.; Ferraro, E.; Safonov, A.; Nelson, K.; Szuhany, K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Cost trends in standard-of-care cancer treatments, 2017-2021
    Meeting Abstract

    Wang, J. J.; Persaud, S.; Tabatabai, S.; Chakraborty, N.; Dey, P.; Trivedi, N. U.; Mitchell, A. P.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Trends in prices of checkpoint inhibitors in the US, 2016-2023
    Meeting Abstract

    Paul, J.; Mitchell, A. P.; Kesselheim, A. S.; Rome, B. N.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Overlapping and non-overlapping indications for checkpoint inhibitors in the US
    Meeting Abstract

    Paul, J.; Mitchell, A. P.; Kesselheim, A. S.; Rome, B. N.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Trends in NCCN enforcement of financial conflict of interest policies for guidelines panelists
    Meeting Abstract

    Bhamidipati, D.; Saririan, N.; Dey, P.; Persaud, S.; Chakraborty, N.; Tabatabai, S.; Gallagher, G. B.; Trivedi, N. U.; Mitchell, A. P.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Associations of dietary fructose with survival of patients (pts) with metastatic cancer of the urothelium (UC) and renal cell carcinoma (RCC) on immune checkpoint blockade (ICB)
    Meeting Abstract

    Badri, A.; Guercio, B. J.; Ratna, N.; Gavrilov, D.; Metzker, N.; Duzgol, C.; Teo, M. Y.; Regazzi, A. M.; Supplice, L.; Funt, S. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save